Association of Parkinsonism and Related Disorders
You are here:
Home -> News -> Parkinson's Disease Neuropsychiatric Features And Fatigue Respond To Transdermal Rotigotine
Other newsitems
Parkinson's Disease Neuropsychiatric Features And Fatigue Respond To Transdermal Rotigotine
Date: 29-04-2012
At the 64th American Academy of Neurology Annual Meeting in New Orleans USA, UCB presented results from their post-hoc analyses of Neupro (rotigotine), which suggests that the drug improves common non-motor symptoms in patients with Parkinson's disease
At the 64th American Academy of Neurology Annual Meeting in New Orleans USA, UCB presented results from their post-hoc analyses of Neupro (rotigotine), which suggests that the drug improves common non-motor symptoms in patients with Parkinson's disease
At the 64th American Academy of Neurology Annual Meeting in New Orleans USA, UCB presented results from their post-hoc analyses of Neupro (rotigotine), which suggests that the drug improves common non-motor symptoms in patients with Parkinson's disease
Association of Parkinsonism and Related Disorders, Van Eeghenstraat 83, 1071 EX Amsterdam, the Netherlands
